Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody response to SARS-CoV-2 infection in humans: a systematic review
Nathan Post, Danielle Eddy, Catherine Huntley, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e598-e609
Open Access | Times Cited: 238
Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity
David Hagin, Tal Freund, Michal Navon, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 3, pp. 739-749
Open Access | Times Cited: 179
Biosensors for the Determination of SARS-CoV-2 Virus and Diagnosis of COVID-19 Infection
Maryia Drobysh, Almira Ramanavičienė, Roman Viter, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 666-666
Open Access | Times Cited: 77
Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination
Andrzej Tretyn, Joanna Szczepanek, Monika Skorupa, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1952-1952
Open Access | Times Cited: 77
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study
Santiago Romero‐Brufau, Ayush Chopra, Alex J Ryu, et al.
BMJ (2021), pp. n1087-n1087
Open Access | Times Cited: 75
Affinity Sensors for the Diagnosis of COVID-19
Maryia Drobysh, Almira Ramanavičienė, Roman Viter, et al.
Micromachines (2021) Vol. 12, Iss. 4, pp. 390-390
Open Access | Times Cited: 68
Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing Immunity
Benjamin T. Bradley, Andrew Bryan, Susan L. Fink, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 9
Open Access | Times Cited: 58
Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
Maurice Steenhuis, Gerard van Mierlo, Ninotska I. L. Derksen, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 5
Open Access | Times Cited: 57
The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review
Monika Gudowska-Sawczuk, Barbara Mroczko
Journal of Clinical Medicine (2021) Vol. 10, Iss. 13, pp. 2772-2772
Open Access | Times Cited: 56
Reduced Titers of Circulating Anti-SARS-CoV-2 Antibodies and Risk of COVID-19 Infection in Healthcare Workers during the Nine Months after Immunization with the BNT162b2 mRNA Vaccine
Luca Coppeta, Cristiana Ferrari, Giuseppina Somma, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 141-141
Open Access | Times Cited: 43
Adaptive Immunity and the Risk of Autoreactivity in COVID-19
Rhiane Moody, Kirsty Wilson, Katie L. Flanagan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8965-8965
Open Access | Times Cited: 45
Role of ILC2 in Viral-Induced Lung Pathogenesis
Wendy Fonseca, Nicholas W. Lukacs, Srikanth Elesela, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 40
Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2
David J. McConnell, Conor Hickey, Norma Bargary, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 9, pp. 4640-4640
Open Access | Times Cited: 34
Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020
Heather F. Gidding, Dorothy A. Machalek, Alexandra Hendry, et al.
The Medical Journal of Australia (2021) Vol. 214, Iss. 4, pp. 179-185
Open Access | Times Cited: 32
Dynamic changes of acquired maternal SARS-CoV-2 IgG in infants
Xia Wang, Pu Yang, Junwen Zheng, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 32
High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events
Evangelos Terpos, Marianna Politou, Ioannis Ntanasis‐Stathopoulos, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 712-712
Open Access | Times Cited: 30
Impact of reproduction number on the multiwave spreading dynamics of COVID-19 with temporary immunity: A mathematical model
B. Shayak, Mohit Sharma, Manas Gaur, et al.
International Journal of Infectious Diseases (2021) Vol. 104, pp. 649-654
Open Access | Times Cited: 28
Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test
Václav Šimánek, Ladislav Pecen, Zuzana Krátká, et al.
Diagnostics (2021) Vol. 11, Iss. 4, pp. 593-593
Open Access | Times Cited: 28
Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients
Emanuele Amodio, Giuseppina Capra, Alessandra Casuccio, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 714-714
Open Access | Times Cited: 28
Seroprevalence of hospital staff in a province with zero COVID-19 cases
Tanawin Nopsopon, Krit Pongpirul, Korn Chotirosniramit, et al.
PLoS ONE (2021) Vol. 16, Iss. 4, pp. e0238088-e0238088
Open Access | Times Cited: 27
Organoid Models of SARS-CoV-2 Infection: What Have We Learned about COVID-19?
Bang M. Tran, Georgia Deliyannis, Abderrahman Hachani, et al.
Organoids (2022) Vol. 1, Iss. 1, pp. 2-27
Open Access | Times Cited: 20
Changes in the Adaptive Cellular Repertoire after Infection with Different SARS-CoV-2 VOCs in a Cohort of Vaccinated Healthcare Workers
Sara Caldrer, Silvia Accordini, Cristina Mazzi, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 230-230
Open Access | Times Cited: 3
Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain
Marianna Karachaliou, Gemma Moncunill, Ana Espinosa, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19
Antonios Kritikos, Sophie Gabellon, Jean‐Luc Pagani, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1089-1089
Open Access | Times Cited: 16
Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature
Marcial Delgado‐Fernández, Gracia Mar García-Gemar, Ana Fuentes, et al.
Enfermedades Infecciosas y Microbiología Clínica (2021) Vol. 40, Iss. 9, pp. 507-516
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top